Gts Securities LLC United Therapeutics Corp Call Options Transaction History

Gts Securities LLC

  • $45.4 Billion
  • Q3 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$311.04 - $363.55 $373,248 - $436,260
-1,200 Reduced 20.34%
4,700 $1.68 Million
Q2 2024

Aug 14, 2024
BUY
$228.26 - $319.04 $342,390 - $478,560
1,500 Added 34.09%
5,900 $1.88 Million
Q1 2024

May 15, 2024
SELL
$210.76 - $249.51 $1.14 Million - $1.35 Million
-5,400 Reduced 55.1%
4,400 $1.01 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $709,104 - $847,902
3,300 Added 50.77%
9,800 $2.15 Million
Q3 2023

Nov 15, 2023
BUY
$211.82 - $248.24 $1.38 Million - $1.61 Million
6,500 New
6,500 $1.47 Million

Others Institutions Holding UTHR

# of Institutions
671
Shares Held
42.3M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email